Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $83.1M $77.6M $55.3M $66.1M $40.7M $50.0M $49.0M $35.8M
Accounts Receivable $79.1M $68.6M $67.7M $59.2M $51.9M $38.7M $35.7M $28.6M
Inventory $76.0M $73.1M $64.4M $51.6M $51.2M $38.3M $35.0M $32.0M
Total Current Assets $375.8M $293.0M $248.2M $231.2M $188.7M $168.4M $143.9M $122.5M
Property, Plant & Equipment $73.1M $61.7M $54.7M $44.5M $41.9M $34.3M $29.9M $22.3M
Goodwill $99.6M $104.8M $88.5M $70.1M $68.2M $59.5M $53.1M $51.6M
Intangible Assets (Excl. Goodwill) $54.7M $54.6M $49.4M $24.2M $25.2M $12.3M $10.8M $17.2M
Total Assets $618.0M $528.4M $449.9M $392.2M $345.3M $290.6M $251.6M $219.7M
Liabilities
Accounts Payable $20.8M $16.2M $15.8M $13.7M $13.4M $9.2M $10.8M $8.5M
Total Current Liabilities $38.7M $36.0M $28.6M $25.5M $25.0M $17.7M $20.0M $17.8M
Long-Term Debt — — — — — — — —
Total Liabilities $57.8M $56.7M $45.8M $41.2M $39.0M $32.3M $32.5M $30.7M
Stockholders' Equity
Retained Earnings $359.1M $295.9M $252.1M $215.6M $182.0M $153.9M $126.7M $104.1M
Total Stockholders' Equity $560.2M $471.6M $404.2M $351.0M $306.4M $258.2M $218.8M $188.6M
← Newer Page 2 of 3 Older →